Diagnostic imaging plays a crucial role in the study of pancreatic tumors, with the primary aims being their correct detection and characterization [1, 2]. A further accurate staging is of fundamental importance for treatment planning. Ultrasonography (US) is often the non invasive imaging modality chosen for the first evaluation of the pancreas, as it is inexpensive, easy to perform and widely available . The more precise and accurate the initial evaluation, the more appropriate the management of the patient will be. In recent decades, the introduction of new technologies has improved the image quality of conventional imaging with very high spatial and contrast resolution [4-6]. Adenocarcinoma is the most common primary malignancy of the pancreas, thus each single pancreatic solid mass detected at US has a high probability of being an adenocarcinoma. Otherwise not all the solid pancreatic masses detected at US are adenocarcinoma . Therefore improving the US capability for the characterization and differential diagnosis will lead to both a faster diagnosis of ductal adenocarcinoma and a more accurate differential diagnosis in respect to other pancreatic tumor histotypes or non-neoplastic mass-forming conditions.
|Title of host publication||Ultrasonography of the Pancreas: Imaging and Pathologic Correlations|
|Publisher||Springer-Verlag Italia s.r.l.|
|Number of pages||18|
|Publication status||Published - Jan 1 2012|
ASJC Scopus subject areas